COSMOS Pharmaceutical Corporation
CSMYF · OTC
5/31/2025 | 5/31/2024 | 5/31/2023 | 5/31/2022 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $57 | $52 | $46 | $37 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $12 | $12 | $13 | $11 |
| Inventory | $92 | $86 | $77 | $66 |
| Other Curr. Assets | $4 | $4 | $13 | $12 |
| Total Curr. Assets | $166 | $154 | $137 | $115 |
| Property Plant & Equip (Net) | $348 | $296 | $275 | $239 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $1 | $0 |
| Long-Term Investments | $0 | $0 | $4 | $4 |
| Tax Assets | $3 | $0 | $2 | $2 |
| Other NC Assets | $8 | $26 | $2 | $2 |
| Total NC Assets | $359 | $322 | $284 | $248 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $525 | $477 | $421 | $363 |
| Liabilities | – | – | – | – |
| Payables | $177 | $180 | $162 | $139 |
| Short-Term Debt | $8 | $7 | $4 | $3 |
| Tax Payable | $12 | $6 | $6 | $5 |
| Deferred Revenue | $0 | $0 | $25 | $19 |
| Other Curr. Liab. | $24 | $22 | $19 | $15 |
| Total Curr. Liab. | $221 | $213 | $192 | $162 |
| LT Debt | $42 | $28 | $14 | $6 |
| Deferred Rev, NC | $0 | $0 | -$0 | -$0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $5 | $4 | $4 | $4 |
| Total NC Liab. | $47 | $32 | $18 | $10 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $7 | $6 | $5 | $5 |
| Total Liabilities | $267 | $245 | $210 | $173 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $4 | $4 | $4 | $4 |
| Retained Earnings | $248 | $222 | $202 | $182 |
| AOCI | $0 | $0 | $0 | $0 |
| Other Equity | $5 | $5 | $4 | $4 |
| Total Equity | $257 | $231 | $211 | $191 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $525 | $477 | $421 | $363 |
| Net Debt | -$7 | -$18 | -$28 | -$28 |